Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and safety of the third dose COVID-19 vaccine in Thai population
TCTR20210731004Phase 2Recruiting
- Sponsor
- Chulabhorn Royal Academy
- Start
- Aug 2021
- Countries
- 1
01
Overview
Phase 2 trial in coronavirus disease 2019 (COVID-19), sponsored by Chulabhorn Royal Academy. Started Aug 2021; status: recruiting.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20210731004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210731004.